Evidence map›Paper›PMID 36759644›Full record

ArticleScientific reports2023

Alternative splicing of the SUMO1/2/3 transcripts affects cellular SUMOylation and produces functionally distinct SUMO protein isoforms.

Myriah L Acuña, Andrea García-Morin, Rebeca Orozco-Sepúlveda, Carlos Ontiveros, Alejandra Flores, Arely V Diaz, Isabel Gutiérrez-Zubiate, Abhijeet R Patil, Luis A Alvarado, Sourav Roy and 2 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 18 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. A Vivo-Morpholino-Based Approach to Block Paralog-Specific SUMOylation.Methods in molecular biology (Clifton, N.J.) · 2025
    Article
  8. Review
  9. Review
  10. The SUMO Pathway.Methods in molecular biology (Clifton, N.J.) · 2025
    Review
  11. Review
  12. Review
  13. Article
  14. Review
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 1 country.

Myriah L Acuña *Department of Biological Sciences, The University of Texas at El Paso, El Paso, TX, 79968, USA.
Andrea García-Morin *Department of Biological Sciences, The University of Texas at El Paso, El Paso, TX, 79968, USA.
Rebeca Orozco-SepúlvedaDepartment of Biological Sciences, The University of Texas at El Paso, El Paso, TX, 79968, USA.
Carlos OntiverosDepartment of Biological Sciences, The University of Texas at El Paso, El Paso, TX, 79968, USA.
Alejandra FloresDepartment of Biological Sciences, The University of Texas at El Paso, El Paso, TX, 79968, USA.
Arely V DiazDepartment of Biological Sciences, The University of Texas at El Paso, El Paso, TX, 79968, USA.
Isabel Gutiérrez-ZubiateDepartment of Biological Sciences, The University of Texas at El Paso, El Paso, TX, 79968, USA.
Abhijeet R PatilDepartment of Genetics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, 19104, USA.
Luis A AlvaradoBiostatistics and Epidemiology Consulting Lab, Texas Tech University Health Sciences Center, El Paso, TX, 79905, USA.
Sourav RoyDepartment of Biological Sciences, The University of Texas at El Paso, El Paso, TX, 79968, USA.
William K RussellDepartment of Biochemistry and Molecular Biology, The University of Texas Medical Branch, Galveston, TX, 77555, USA.
Germán Rosas-AcostaDepartment of Biological Sciences, The University of Texas at El Paso, El Paso, TX, 79968, USA. grosas3@utep.edu.
The University of Texas at El Paso · USTexas Tech University Health Sciences Center · USThe University of Texas Medical Branch at Galveston · USUniversity of Colorado Anschutz Medical Campus · USUniversity of Pennsylvania · US

Funding

TCCG12MD007592 · NIMHD · UNIVERSITY OF TEXAS EL PASO · PI KIRKEN, ROBERT A. · 2012 to 2018
$19.4M
Phase II of BUILDing SCHOLARSUL1GM118970 · NIGMS · UNIVERSITY OF TEXAS EL PASO · PI ALEY, STEPHEN B, BOLAND, THOMAS · 2015 to 2023
$17.9M
Phase II of BUILDing SCHOLARS - Student Training CoreTL4GM118971 · NIGMS · UNIVERSITY OF TEXAS EL PASO · PI ALEY, STEPHEN B, BOLAND, THOMAS · 2015 to 2023
$9.9M
Undergraduate Biomedical Research Training at UTEPT34GM008048 · NIGMS · UNIVERSITY OF TEXAS EL PASO · PI PANNELL, KEITH H · 1985 to 2020
$9.2M
Phase II of BUILDing SCHOLARS - Research Enrichment CoreRL5GM118969 · NIGMS · UNIVERSITY OF TEXAS EL PASO · PI ALEY, STEPHEN B, BOLAND, THOMAS · 2015 to 2023
$7.4M
NIGMS NIH HHS RL5 GM118969NIGMS NIH HHS RL5GM118969NIGMS NIH HHS T34 GM008048NIGMS NIH HHS TL4 GM118971NIGMS NIH HHS TL4GM118971NIGMS NIH HHS UL1 GM118970NIGMS NIH HHS UL1GM118970NIMHD NIH HHS G12 MD007592
6 · The paper itself

Abstract

Substantial increases in the conjugation of the main human SUMO paralogs, SUMO1, SUMO2, and SUMO3, are observed upon exposure to different cellular stressors, and such increases are considered important to facilitate cell survival to stress. Despite their critical cellular role, little is known about how the levels of the SUMO modifiers are regulated in the cell, particularly as it relates to the changes observed upon stress. Here we characterize the contribution of alternative splicing towards regulating the expression of the main human SUMO paralogs under normalcy and three different stress conditions, heat-shock, cold-shock, and Influenza A Virus infection. Our data reveal that the normally spliced transcript variants are the predominant mature mRNAs produced from the SUMO genes and that the transcript coding for SUMO2 is by far the most abundant of all. We also provide evidence that alternatively spliced transcripts coding for protein isoforms of the prototypical SUMO proteins, which we refer to as the SUMO alphas, are also produced, and that their abundance and nuclear export are affected by stress in a stress- and cell-specific manner. Additionally, we provide evidence that the SUMO alphas are actively synthesized in the cell as their coding mRNAs are found associated with translating ribosomes. Finally, we provide evidence that the SUMO alphas are functionally different from their prototypical counterparts, with SUMO1α and SUMO2α being non-conjugatable to protein targets, SUMO3α being conjugatable but targeting a seemingly different subset of protein from those targeted by SUMO3, and all three SUMO alphas displaying different cellular distributions from those of the prototypical SUMOs. Thus, alternative splicing appears to be an important contributor to the regulation of the expression of the SUMO proteins and the cellular functions of the SUMOylation system.

Indexed as

Alternative SplicingSumoylationGenes, RegulatorHumansProtein IsoformsSmall Ubiquitin-Related Modifier ProteinsSUMO-1 ProteinProtein IsoformsSmall Ubiquitin-Related Modifier ProteinsSUMO-1 ProteinSUMO1 protein, human

Identifiers

PMID36759644
PMCPMC9911741
OpenAlexW4319748084

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.